ARTICLES ON VALVULOPATHIES
Percutaneous solutions for tricuspid regurgitation: the new frontier of structural cardiology
This review summarizes the latest technical advances, patient selection criteria, and available evidence regarding percutaneous approaches for tricuspid regurgitation (TR).
Transcatheter aortic valve implantation in bicuspid aortic valves: present and future
This expert review summarizes the current evidence regarding transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves (BAV), addressing the main procedural challenges, preprocedural imaging strategies, and future perspectives in this evolving field.
Nidus: the registry redefining surgery in infective endocarditis
The Danish NIDUS registry provides one of the most comprehensive contemporary series on left-sided infective endocarditis, with particular emphasis on the role of surgery in real-world clinical practice.
Edge-to-edge tricuspid valve repair and heart failure hospitalizations: the TRI-SPA registry
Multicenter retrospective registry evaluating patients undergoing transcatheter tricuspid edge-to-edge repair, with specific focus on the impact of prior heart failure hospitalizations on mortality and readmissions.
Transcarotid access in TAVI versus surgery: early advantage and comparable one-year outcomes
This single-center observational study compared the outcomes of transcarotid transcatheter aortic valve implantation (TC-TAVI) with those of conventional surgical aortic valve replacement (SAVR) in patients with severe aortic stenosis who were not suitable candidates for transfemoral access.
Mitraclip in octogenarians with degenerative mitral regurgitation: the impossible comparison
A recent study compared outcomes of transcatheter edge-to-edge repair (Abbott MitraClip®) versus surgical mitral repair in octogenarian patients with severe organic mitral regurgitation, aiming to evaluate safety, efficacy, and midterm outcomes
Transcarotid vascular access for transcatheter aortic valve implantation: is choosing the left side always right?
Retrospective analysis of 46 patients who underwent transcarotid TAVI at a single Swiss center, focusing on two quantifiable parameters derived from preoperative CT angiography.
Surgical treatment of tricuspid regurgitation: a new ally in patients with long-term ventricular assist devices?
A randomized US trial aimed to determine whether concomitant tricuspid valve surgery (TVS) at the time of durable left ventricular assist device (LVAD) implantation reduces tricuspid regurgitation (TR) and the incidence of long-term right heart failure (RHF).
TAVI in patients younger than 65 years: when evidence has not yet reached the age of the patients
A new U.S. study analyzes outcomes of transcatheter aortic valve implantation (TAVI) versus conventional surgical aortic valve replacement (SAVR) in patients younger than 65 years, highlighting the growing expansion of TAVI despite limited evidence on long-term durability.
New european guidelines on valvular heart disease 2025: the most relevant changes for surgical practice
The 2025 ESC/EACTS update redefines the boundaries between surgery and transcatheter therapy. It advocates earlier intervention in severe aortic stenosis, lowers the age threshold for TAVI to 70 years, expands the use of MitraClip to lower-risk scenarios, promotes percutaneous tricuspid treatment, and grants a new central role to advanced imaging in decision-making.